Key Highlights

  • Advanced Micro Devices (NASDAQ:AMD) reported third quarter Revenue up 45% to a record USD 13.4 billion, with Data Center revenue up 97% to USD 8.5 billion and fourth quarter guidance near USD 17 billion.
  • Amgen (NASDAQ:AMGN) grew total revenues 8% to USD 10.4 billion, while Prolia sales fell 45% to USD 632 million as Biosimilars launched.
  • Prudential Financial (NYSE:PRU) reported after-tax adjusted Operating Income of USD 3.77 per share against USD 4.05, as Japan Businesses income fell to USD 559 million from USD 750 million.
  • Booking Holdings (NASDAQ:BKNG) reported global room night growth of 7% in the third quarter, up from 5% in the second quarter, and raised its savings target to USD 650 million.

Advanced Micro Devices (NASDAQ:AMD): Data Center Nearly Doubles

Advanced Micro Devices (NASDAQ:AMD) reported third quarter 2026 results on November 3, 2026, with revenue of USD 13.377 billion against USD 9.246 billion a year earlier. Revenue exceeded the high end of company guidance. Data Center revenue of USD 8.5 billion rose 97% on Demand for EPYC processors and the launch of Instinct MI450 series GPUs. Embedded revenue grew 29% to USD 1.1 billion and Client revenue rose 7% to USD 2.9 billion. Gaming revenue fell 40% to USD 773 million, which held Client and Gaming segment revenue to USD 3.7 billion. GAAP Diluted Earnings per Share were USD 1.46, and non-GAAP earnings per share were USD 2.09, up 74%. The non-GAAP figure excludes a USD 1,097 million change in the Fair Value of a Warrant Liability tied to warrants issued to certain customers. Fourth quarter revenue is guided to about USD 17 billion, plus or minus 3%, with non-GAAP gross Margin near 55%, slightly below the 56% just reported. The guide implies about USD 3.6 billion of added quarterly revenue at the midpoint (own arithmetic). Risks include export rules, tariffs, memory and substrate Supply and Manufacturing yields.

Amgen (NASDAQ:AMGN): Volume Growth Offsets Biosimilar Erosion

Amgen (NASDAQ:AMGN) announced third quarter 2026 results on November 3, 2026. Total revenues rose 8% to USD 10.4 billion, with product sales of USD 9.883 billion, driven by volume growth. Repatha sales rose 37% to USD 1,085 million and Imdelltra rose 128% to USD 406 million. Prolia fell 45% and Xgeva fell 47% as multiple biosimilar denosumab products launched. GAAP earnings per share were USD 7.08 and non-GAAP earnings per share were USD 6.45, up 14%. The GAAP Operating Margin rose 9.9 points to 37.5%, but the non-GAAP operating margin rose only 0.2 points to 47.3%, because non-GAAP operating expenses rose 8%. Free Cash Flow was USD 3.7 billion against USD 4.2 billion a year earlier. Cash was USD 13.2 billion and Debt USD 54.0 billion, and no shares were repurchased in the quarter. Full-year 2026 non-GAAP earnings per share guidance is USD 22.90 to USD 23.70. Several Phase 3 studies of obesity candidate MariTide are ongoing, with no data in the material reviewed. Enbrel net selling price fell 14% under Medicare Part D price setting.

Prudential Financial (NYSE:PRU): Japan Sales Suspension Pressures Earnings

Prudential Financial (NYSE:PRU) reported third quarter 2026 results on November 3, 2026. Net Income attributable to the company was USD 1.388 billion, or USD 3.96 per share, against USD 1.431 billion, or USD 4.01. After-tax adjusted operating income, a non-GAAP measure, was USD 3.77 per share against USD 4.05. Lower earnings in Japan tied to the sales suspension at Prudential of Japan more than offset solid fundamentals at PGIM and in the U.S. businesses. When a life insurer stops selling, new-business production falls immediately, in this case by 36% on a constant dollar basis to USD 291 million, while fixed costs continue. Japan lost USD 191 million of pre-tax operating income year over year (simple arithmetic on two reported figures). PGIM reported third-party net inflows of USD 9.0 billion, the highest in 10 quarters. Capital returned totaled USD 741 million, and Parent Company Liquid assets were USD 4.0 billion. Japan sales stay suspended with no restart date in the release, and U.S. Legacy Products earnings fell to USD 253 million from USD 308 million. A call was set for November 4, 2026, at 11:00 a.m. ET.

Booking Holdings (NASDAQ:BKNG): Room Nights Accelerate Despite Conflict

Booking Holdings (NASDAQ:BKNG) filed its Quarterly Report for the period ended September 30, 2026 on November 3, 2026. Global room nights increased 7% in the third quarter, an acceleration from 5% in the second quarter, mainly because international travel from Europe and Asia improved. Constant-currency average daily rates were about 3% higher. Multiplying those two rates gives roughly 10% growth in room night value before currency effects (own arithmetic, not a reported figure). Marketing expenses totaled USD 2.6 billion, up 11%. The merchant share of gross bookings reached 75%, which adds revenue such as card rebates but also payment processing and chargeback costs that weigh on margin. The Transformation Program target was raised to USD 650 million of run-rate savings from about USD 550 million, with most of the increase expected in 2027. The filing warns that traffic from organic search is expected to decline, which may raise paid marketing spend. Alternative stays made up about 37% of room nights, up from 36%, and carry lower margins or extra costs. Revenue, gross bookings and profit figures were not in the extract reviewed.

Where Things Stand

Advanced Micro Devices stands apart because Data Center revenue grew 97% and revenue beat the top of company guidance. Advanced Micro Devices (NASDAQ:AMD) guided the next quarter to about USD 17 billion, though that depends on turning early deployments into volume production. Amgen (NASDAQ:AMGN) grew 8% by volume while losing Prolia and Xgeva sales to biosimilars, and its non-GAAP margin was nearly flat. Prudential Financial (NYSE:PRU) earned less per share as Japan sales stayed suspended. Booking Holdings (NASDAQ:BKNG) showed faster room night growth, but the extract lacked profit figures. Watch the AMD fourth quarter report, Amgen's MariTide readouts, any Japan restart and Booking's savings delivery.